6-methyl-2-[[(1S)-1-pyridin-3-ylethyl]amino]-N-(pyridin-2-ylmethyl)thieno[3,2-d]pyrimidine-4-carboxamide
C21H20N6OS — CID 150752857
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-methyl-2-[[(1S)-1-pyridin-3-ylethyl]amino]-N-(pyridin-2-ylmethyl)thieno[3,2-d]pyrimidine-4-carboxamide
6-methyl-2-[[(1S)-1-pyridin-3-ylethyl]amino]-N-(pyridin-2-ylmethyl)thieno[3,2-d]pyrimidine-4-carboxamide (PubChem CID 150752857) has the molecular formula C21H20N6OS and a molecular weight of 404.50 g/mol. Its IUPAC name is 6-methyl-2-[[(1S)-1-pyridin-3-ylethyl]amino]-N-(pyridin-2-ylmethyl)thieno[3,2-d]pyrimidine-4-carboxamide.
Molecular Properties
| Compound Name | 6-methyl-2-[[(1S)-1-pyridin-3-ylethyl]amino]-N-(pyridin-2-ylmethyl)thieno[3,2-d]pyrimidine-4-carboxamide |
|---|---|
| PubChem CID | 150752857 |
| Molecular Formula | C21H20N6OS |
| Molecular Weight | 404.50 g/mol |
| Exact Mass | 404.14 |
| IUPAC Name | 6-methyl-2-[[(1S)-1-pyridin-3-ylethyl]amino]-N-(pyridin-2-ylmethyl)thieno[3,2-d]pyrimidine-4-carboxamide |
| SMILES | Cc1cc2nc(N[C@@H](C)c3cccnc3)nc(C(=O)NCc3ccccn3)c2s1 |
| InChI | InChI=1S/C21H20N6OS/c1-13-10-17-19(29-13)18(20(28)24-12-16-7-3-4-9-23-16)27-21(26-17)25-14(2)15-6-5-8-22-11-15/h3-11,14H,12H2,1-2H3,(H,24,28)(H,25,26,27)/t14-/m0/s1 |
| InChIKey | JWFXEJTXXSQUCX-AWEZNQCLSA-N |
| XLogP | 3.89 |
| TPSA | 92.69 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 404.50 |
| LogP ≤ 5 | 3.89 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 150752857 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.